Bessemer Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243K | Sell |
4,429
-189
| -4% | -$10.4K | ﹤0.01% | 1056 |
|
|
2025
Q1 | $327K | Sell |
4,618
-683
| -13% | -$48.4K | ﹤0.01% | 973 |
|
|
2024
Q4 | $349K | Buy |
5,301
+281
| +6% | +$18.5K | ﹤0.01% | 974 |
|
|
2024
Q3 | $353K | Sell |
5,020
-195
| -4% | -$13.7K | ﹤0.01% | 985 |
|
|
2024
Q2 | $429K | Hold |
5,215
| – | – | ﹤0.01% | 836 |
|
|
2024
Q1 | $455K | Hold |
5,215
| – | – | ﹤0.01% | 835 |
|
|
2023
Q4 | $503K | Sell |
5,215
-107
| -2% | -$10.3K | ﹤0.01% | 820 |
|
|
2023
Q3 | $471K | Buy |
5,322
+107
| +2% | +$9.47K | ﹤0.01% | 817 |
|
|
2023
Q2 | $452K | Hold |
5,215
| – | – | ﹤0.01% | 848 |
|
|
2023
Q1 | $507K | Hold |
5,215
| – | – | ﹤0.01% | 724 |
|
|
2022
Q4 | $540K | Sell |
5,215
-395
| -7% | -$40.9K | ﹤0.01% | 707 |
|
|
2022
Q3 | $476K | Buy |
+5,610
| New | +$476K | ﹤0.01% | 740 |
|
|
2022
Q2 | – | Sell |
-393
| Closed | -$30K | – | 1881 |
|
|
2022
Q1 | $30K | Hold |
393
| – | – | ﹤0.01% | 1172 |
|
|
2021
Q4 | $35K | Sell |
393
-168
| -30% | -$15K | ﹤0.01% | 1183 |
|
|
2021
Q3 | $43K | Sell |
561
-76
| -12% | -$5.83K | ﹤0.01% | 1081 |
|
|
2021
Q2 | $53K | Hold |
637
| – | – | ﹤0.01% | 1053 |
|
|
2021
Q1 | $49K | Buy |
637
+600
| +1,622% | +$46.2K | ﹤0.01% | 1013 |
|
|
2020
Q4 | $3K | Hold |
37
| – | – | ﹤0.01% | 1410 |
|
|
2020
Q3 | $3K | Hold |
37
| – | – | ﹤0.01% | 1232 |
|
|
2020
Q2 | $5K | Buy |
+37
| New | +$5K | ﹤0.01% | 1561 |
|
|
2019
Q4 | – | Sell |
-314,132
| Closed | -$21.2M | – | 1643 |
|
|
2019
Q3 | $21.2M | Sell |
314,132
-21,868
| -7% | -$1.47M | 0.08% | 189 |
|
|
2019
Q2 | $28.8M | Buy |
336,000
+335,874
| +266,567% | +$28.8M | 0.1% | 181 |
|
|
2019
Q1 | $11K | Buy |
126
+78
| +163% | +$6.81K | ﹤0.01% | 1484 |
|
|
2018
Q4 | $4K | Buy |
+48
| New | +$4K | ﹤0.01% | 1810 |
|
|
2018
Q1 | – | Sell |
-350
| Closed | -$31K | – | 1698 |
|
|
2017
Q4 | $31K | Hold |
350
| – | – | ﹤0.01% | 1331 |
|
|
2017
Q3 | $33K | Buy |
350
+114
| +48% | +$10.7K | ﹤0.01% | 1370 |
|
|
2017
Q2 | $21K | Buy |
+236
| New | +$21K | ﹤0.01% | 1467 |
|
|
2017
Q1 | – | Sell |
-50
| Closed | -$4K | – | 1754 |
|
|
2016
Q4 | $4K | Sell |
50
-107
| -68% | -$8.56K | ﹤0.01% | 1770 |
|
|
2016
Q3 | $15K | Buy |
157
+155
| +7,750% | +$14.8K | ﹤0.01% | 1433 |
|
|
2016
Q2 | $0 | Sell |
2
-837
| -100% | – | ﹤0.01% | 1318 |
|
|
2016
Q1 | $70K | Buy |
839
+610
| +266% | +$50.9K | ﹤0.01% | 849 |
|
|
2015
Q4 | $24K | Buy |
229
+57
| +33% | +$5.97K | ﹤0.01% | 1094 |
|
|
2015
Q3 | $18K | Buy |
172
+94
| +121% | +$9.84K | ﹤0.01% | 1122 |
|
|
2015
Q2 | $11K | Hold |
78
| – | – | ﹤0.01% | 1218 |
|
|
2015
Q1 | $10K | Buy |
+78
| New | +$10K | ﹤0.01% | 1221 |
|
|
2014
Q3 | – | Sell |
-257
| Closed | -$16K | – | 1257 |
|
|
2014
Q2 | $16K | Buy |
+257
| New | +$16K | ﹤0.01% | 1045 |
|